{"title":"更正：FLT3突变急性髓性白血病干细胞移植后维持治疗--一项回顾性分析：米哚妥林可改善疗效，吉特替尼则不然。","authors":"","doi":"10.1002/jha2.948","DOIUrl":null,"url":null,"abstract":"<p>Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan AA, et al. “Post-stem cell transplant maintenance in FLT3<sup>mut</sup> acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.” <i>Eur J Haematol</i>. 2024;5(2):423–27. https://doi.org/10.1002/jha2.885</p><p>The title of the letter should read “Post-hematopoietic stem cell transplant FLT3 inhibitor maintenance therapy improves outcomes in acute myeloid leukemia: Real-world insights and clinical implications.”</p><p>We apologize for this error.</p>","PeriodicalId":72883,"journal":{"name":"EJHaem","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182404/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction to: Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib\",\"authors\":\"\",\"doi\":\"10.1002/jha2.948\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan AA, et al. “Post-stem cell transplant maintenance in FLT3<sup>mut</sup> acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.” <i>Eur J Haematol</i>. 2024;5(2):423–27. https://doi.org/10.1002/jha2.885</p><p>The title of the letter should read “Post-hematopoietic stem cell transplant FLT3 inhibitor maintenance therapy improves outcomes in acute myeloid leukemia: Real-world insights and clinical implications.”</p><p>We apologize for this error.</p>\",\"PeriodicalId\":72883,\"journal\":{\"name\":\"EJHaem\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182404/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJHaem\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jha2.948\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJHaem","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jha2.948","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Correction to: Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib
Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan AA, et al. “Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia – A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.” Eur J Haematol. 2024;5(2):423–27. https://doi.org/10.1002/jha2.885
The title of the letter should read “Post-hematopoietic stem cell transplant FLT3 inhibitor maintenance therapy improves outcomes in acute myeloid leukemia: Real-world insights and clinical implications.”
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
